Literature DB >> 25309633

Matching methods for obtaining survival functions to estimate the effect of a time-dependent treatment.

Yun Li1, Douglas E Schaubel1, Kevin He1.   

Abstract

In observational studies of survival time featuring a binary time-dependent treatment, the hazard ratio (an instantaneous measure) is often used to represent the treatment effect. However, investigators are often more interested in the difference in survival functions. We propose semiparametric methods to estimate the causal effect of treatment among the treated with respect to survival probability. The objective is to compare post-treatment survival with the survival function that would have been observed in the absence of treatment. For each patient, we compute a prognostic score (based on the pre-treatment death hazard) and a propensity score (based on the treatment hazard). Each treated patient is then matched with an alive, uncensored and not-yet-treated patient with similar prognostic and/or propensity scores. The experience of each treated and matched patient is weighted using a variant of Inverse Probability of Censoring Weighting to account for the impact of censoring. We propose estimators of the treatment-specific survival functions (and their difference), computed through weighted Nelson-Aalen estimators. Closed-form variance estimators are proposed which take into consideration the potential replication of subjects across matched sets. The proposed methods are evaluated through simulation, then applied to estimate the effect of kidney transplantation on survival among end-stage renal disease patients using data from a national organ failure registry.

Entities:  

Keywords:  Causal inference; Matching; Observational study; Propensity score; Survival function; Time-dependent treatment

Year:  2014        PMID: 25309633      PMCID: PMC4188446          DOI: 10.1007/s12561-013-9085-x

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  21 in total

1.  Causal inference on the difference of the restricted mean lifetime between two groups.

Authors:  P Y Chen; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.

Authors:  Babette A Brumback; Miguel A Hernán; Sebastien J P A Haneuse; James M Robins
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

3.  A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.

Authors:  Chiu-Hsieh Hsu; Jeremy M G Taylor
Journal:  Stat Med       Date:  2010-09-20       Impact factor: 2.373

4.  Intervening on risk factors for coronary heart disease: an application of the parametric g-formula.

Authors:  Sarah L Taubman; James M Robins; Murray A Mittleman; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2009-04-23       Impact factor: 7.196

5.  The control of confounding by intermediate variables.

Authors:  J Robins
Journal:  Stat Med       Date:  1989-06       Impact factor: 2.373

6.  A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods.

Authors:  J Robins
Journal:  J Chronic Dis       Date:  1987

7.  Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Authors:  Miguel A Hernán; Stephen R Cole; Joseph Margolick; Mardge Cohen; James M Robins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

8.  A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies.

Authors:  Douglas E Schaubel; Robert A Wolfe; Friedrich K Port
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

9.  Average causal effects from nonrandomized studies: a practical guide and simulated example.

Authors:  Joseph L Schafer; Joseph Kang
Journal:  Psychol Methods       Date:  2008-12

10.  Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data.

Authors:  Hans C van Houwelingen; Hein Putter
Journal:  Lifetime Data Anal       Date:  2008-10-03       Impact factor: 1.588

View more
  12 in total

1.  Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Authors:  Konstantinos C Siontis; Xiaosong Zhang; Ashley Eckard; Nicole Bhave; Douglas E Schaubel; Kevin He; Anca Tilea; Austin G Stack; Rajesh Balkrishnan; Xiaoxi Yao; Peter A Noseworthy; Nilay D Shah; Rajiv Saran; Brahmajee K Nallamothu
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

2.  Time-dependent prognostic score matching for recurrent event analysis to evaluate a treatment assigned during follow-up.

Authors:  Abigail R Smith; Douglas E Schaubel
Journal:  Biometrics       Date:  2015-08-21       Impact factor: 2.571

Review 3.  Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies.

Authors:  Yimei Li; Wei-Ting Hwang; Shannon L Maude; David T Teachey; Noelle V Frey; Regina M Myers; Allison Barz Leahy; Hongyan Liu; David L Porter; Stephan A Grupp; Pamela A Shaw
Journal:  Clin Cancer Res       Date:  2022-09-15       Impact factor: 13.801

4.  Length-biased semi-competing risks models for cross-sectional data: an application to current duration of pregnancy attempt data.

Authors:  Alexander C McLain; Siyuan Guo; Jiajia Zhang; Thoma Marie
Journal:  Ann Appl Stat       Date:  2021-07-12       Impact factor: 1.959

5.  Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.

Authors:  Hirotaka Komaba; Mia Wang; Masatomo Taniguchi; Suguru Yamamoto; Takanobu Nomura; Douglas E Schaubel; Abigail R Smith; Jarcy Zee; Angelo Karaboyas; Brian Bieber; Masafumi Fukagawa; Francesca Tentori
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-19       Impact factor: 8.237

6.  Estimating the effect of a rare time-dependent treatment on the recurrent event rate.

Authors:  Abigail R Smith; Danting Zhu; Nathan P Goodrich; Robert M Merion; Douglas E Schaubel
Journal:  Stat Med       Date:  2018-02-26       Impact factor: 2.373

7.  Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome.

Authors:  Leslie B Gordon; Heather Shappell; Joe Massaro; Ralph B D'Agostino; Joan Brazier; Susan E Campbell; Monica E Kleinman; Mark W Kieran
Journal:  JAMA       Date:  2018-04-24       Impact factor: 56.272

8.  Displaying survival of patient groups defined by covariate paths: Extensions of the Kaplan-Meier estimator.

Authors:  Melissa Jay; Rebecca A Betensky
Journal:  Stat Med       Date:  2021-02-02       Impact factor: 2.373

9.  Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis.

Authors:  Keziah Cook; Omer Ali; Baris Akinci; Maria Cristina Foss de Freitas; Renan Magalhães Montenegro; Virginia Oliveira Fernandes; Deepshekhar Gupta; Kai-Jye Lou; Edward Tuttle; Elif A Oral; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

10.  Black Race Is Associated With Higher Rates of Early-Onset End-Stage Renal Disease and Increased Mortality Following Liver Transplantation.

Authors:  Meagan Alvarado; Douglas E Schaubel; K Rajender Reddy; Therese Bittermann
Journal:  Liver Transpl       Date:  2021-04-21       Impact factor: 6.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.